Yan Yan

TL;DR: PCCL19 and pCCL28 can enhance HIV-1 envelope–specific systemic and mucosal Ab responses, as well as T cell responses, and such enhancements appear to be associated with mobilization of responsive immunocytes into secondary lymphoid organs and mucosa tissues through interactions with corresponding receptors.

TL;DR: It is demonstrated that productive HSV-2 infection suppresses Sendai virus (SeV) or polyinosinic-polycytidylic acid-induced IFN-β production, and it is revealed that US1, an immediate-early protein of HSv-2, contributes to such suppression, demonstrating an unconventional strategy exploited by a dsDNA virus to interrupt type I IFN signaling pathway.

TL;DR: These findings indicate that enhanced humoral and cellular immune responses can be achieved by immunization with an immunogen fused to a chemokine, providing information for the design of vaccines against mucosal infection by HSV-2 and other sexually transmitted viruses.

TL;DR: HAART use is beneficial in decreasing the EBV salivary shedding in HIV/AIDS patients and indirectly decreases EBV transmission risk, according to a retrospective cohort study of EBV serological tests for patients in China.